World's Best Scientists 2026 revealed!
Françoise Brun-Vézinet

Françoise Brun-Vézinet

D-Index & Metrics

Microbiology

D-Index
73
Citations
21250
World Ranking
1640
National Ranking
99

Overview

Françoise Brun-Vézinet is affiliated with Université Paris Cité in France. Their research activity spans several fields mainly within medicine and immunology and microbiology. The scientist has contributed to subfields including epidemiology, virology, infectious diseases, immunology, and hepatology.

The main topics of Brun-Vézinet's work focus extensively on HIV research and treatment, HIV/AIDS research and interventions, and the development of HIV/AIDS drug treatments. Additional topics covered in their research encompass pneumonia and respiratory infections, Pneumocystis jirovecii pneumonia detection and treatment, hepatitis C virus research, and immune cell function and interaction.

  • Their frequent co-authors include Sophie Matheron, Brigitte Autran, Victoire de Lastours, É. Rouveix, and J. Grenet.

  • The Lancet
  • Clinical Microbiology and Infection
  • The Lancet HIV
  • SSRN Electronic Journal
  • Clinical Infectious Diseases

Recent publications authored or co-authored by Françoise Brun-Vézinet are as follows:

  • Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial, 2021, The Lancet
  • Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial, 2024, Clinical Microbiology and Infection
  • Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial, 2024, The Lancet HIV
  • Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection, 2020, Frontiers in Immunology
  • A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected Nonprogressors, 2020, AIDS Research and Human Retroviruses

Best Publications

  • Isolation of a new human retrovirus from West African patients with AIDS.

    F Clavel;D Guétard;F Brun-Vézinet;S Chamaret

  • Identification of a new human immunodeficiency virus type 1 distinct from group M and group O

    François Simon;Philippe Mauclère;Pierre Roques;Ibtissam Loussert-Ajaka

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Update of the Drug Resistance Mutations in HIV-1: 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy

    D Descamps;P Flandre;V Calvez;G Peytavin

  • Weekly Pulse Methotrexate in Rheumatoid Arthritis: Clinical and Immunologic Effects in a Randomized, Double-Blind Study

    Peter A. Andersen;Sterling G. West;James R. O'dell;Charles S. Via

  • Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

    Jean-Luc Meynard;Muriel Vray;Laurence Morand-Joubert;Esther Race

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patients

    I. Loussert-Ajaka;F. Brun-Vézinet;F. Simon;T.D. Ly

  • A Randomized Trial of Three Maintenance Regimens Given after Three Months of Induction Therapy with Zidovudine, Lamivudine, and Indinavir in Previously Untreated HIV-1–Infected Patients

    Gilles Pialoux;François Raffi;Françoise Brun-Vezinet;Vincent Meiffrédy

  • DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME

    F. Brun-Vezinet;F. Barre-Sinoussi;A.G. Saimot;D. Christol

  • Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

    D Descamps;G Collin;F Letourneur;C Apetrei

  • Update of the drug resistance mutations in HIV-1: Fall 2006.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Daniel R Kuritzkes

  • Cellular and plasma viral load in patients infected with HIV-2

    F Simon;S Matheron;C Tamalet;I Loussert-Ajaka

  • Identification of a Highly Divergent HIV Type 2 and Proposal for a Change in HIV Type 2 Classification

    Florence Damond;Michael Worobey;Pauline Campa;Isabelle Farfara

  • env Sequences of Simian Immunodeficiency Viruses from Chimpanzees in Cameroon Are Strongly Related to Those of Human Immunodeficiency Virus Group N from the Same Geographic Area

    Sylvie Corbet;Michaela C. Müller-Trutwin;Pierre Versmisse;Severine Delarue

  • Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France.

    I Loussert-Ajaka;M L Chaix;B Korber;F Letourneur

  • Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients.

    F. Brun-Vezinet;C. Katlama;D. Roulot;L. Lenoble

  • Update of the drug resistance mutations in HIV-1: December 2009.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

Frequent Co-Authors

François Simon
François Simon Université Paris Cité
Sophie Matheron
Sophie Matheron Université Paris Cité
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Bernard Masquelier
Bernard Masquelier University of Bordeaux
Florence Damond
Florence Damond Hôpital Bichat-Claude-Bernard
Catherine Tamalet
Catherine Tamalet Aix-Marseille University
Jacques Izopet
Jacques Izopet Federal University of Toulouse Midi-Pyrénées

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to a variety of related careers and educational paths. For those interested in healthcare, becoming a functional nurse practitioner can be a rewarding option, leveraging biological knowledge to provide holistic patient care.

Students with unique backgrounds may find hope in tailored programs designed to support second chances. Online education platforms provide some of the degrees felons can get, allowing individuals to rebuild their careers and contribute meaningfully to fields like microbiology and public health.

For those drawn to specialized healthcare roles beyond direct patient care, becoming a CPC (Certified Professional Coder) offers a viable pathway. This career focuses on medical coding, crucial for healthcare administration and billing.

Additionally, careers such as child life specialists salary indicate opportunities where understanding biology can improve patient outcomes in pediatric settings. These diverse pathways complement microbiology studies by combining science with practical applications in health and wellness sectors.

Best Scientists Citing Françoise Brun-Vézinet

Trending Scientists

Recently Published Articles